Tanguy, M., Cabel, L., Berger, F., Pierga, J., Savignoni, A., & Bidard, F. (2018). Cdk4/6 inhibitors and overall survival: Power of first-line trials in metastatic breast cancer. NPJ Breast Cancer.
Stile di citazione ChicagoTanguy, Marie-Laure, Luc Cabel, Fréderique Berger, Jean-Yves Pierga, Alexia Savignoni, e Francois-Clement Bidard. "Cdk4/6 Inhibitors and Overall Survival: Power of First-line Trials in Metastatic Breast Cancer." NPJ Breast Cancer 2018.
Citazione MLATanguy, Marie-Laure, et al. "Cdk4/6 Inhibitors and Overall Survival: Power of First-line Trials in Metastatic Breast Cancer." NPJ Breast Cancer 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.